Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.00−0.08 (-0.88%)
Close on Nov 18, 2026Market cap $40.97MP/E –Yield –
Harvard Bioscience pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Harvard Bioscience's pe ratio was 489.0× on Jul 31, 2015, against 66.9× a year earlier. Over the last 4 years it ranged from 6.2× to 570.0×, with a median of 29.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jul 31, 2015 | 489.0× | +375.6 |
| 2014 | Dec 31, 2014 | 113.4× | −16.6 |
| 2013 | Oct 31, 2013 | 130.0× | +96.3 |
| 2012 | Dec 31, 2012 | 33.7× | +27.5 |
| 2011 | Dec 30, 2011 | 6.2× | −10.8 |
| 2010 | Dec 31, 2010 | 17.0× | – |
See a number that looks wrong?